Methodological Note

This section reflects PICRUSt2-predicted metabolic potential derived from 16S-based gene content, not direct metabolite measurement. Results are interpreted as percentile bands versus a reference cohort of n=623, so this report describes what the microbiome could do functionally, rather than confirming actual metabolite exposure. In this basket, the pathways are broadly active in the reference cohort, so percentile comparisons are generally directly interpretable.

Executive Summary

• This basket shows OPTIMAL overall functional status, with no extreme outliers in the active percentile-scored metrics.
• The strongest favorable features are ArAT_Transaminase_Benefit in P75-P95, suggesting good routing of tyrosine toward a more energy-oriented, less toxic pathway, and TBBI_Tyrosine_Bifurcation in P75-P95, supporting a favorable balance between beneficial tyrosine handling and phenol/p-cresol/tyramine-producing routes.
• A second reassuring pattern is the low UTPI_Uremic_Toxin_Production in P5-P25, which is favorable for the uremic-toxin ratio, together with BAI_Histamine in P5-P25, indicating relatively restrained histamine-production potential.
• The main mild variation is a high-normal urease/ammonia axis, which is worth contextual note but does not reach an extreme-outlier range in this profile.

Key Deviations (Outside P25-P75)

No extreme outliers identified (no metrics in P0-P5 or P95-P99/P99-P100). The following findings are outside the interquartile range but remain mild, non-clinical variations in this basket.

(a) WARNING / risk in HIGH band — UNFAVORABLE direction.

• TPL_Phenol_Risk (P75-P95): mildly elevated phenol-production potential from tyrosine.
• Urease_Total_Activity (P75-P95): mildly elevated overall urease capacity, consistent with somewhat greater ammonia-generation potential.
• Urease_ABC_Colocalized (P75-P95): mildly elevated structurally organized urease potential, supporting functional ammonia production.
• Urease_Partial_Complex (P75-P95): mildly elevated partial urease-complex potential, suggesting available activation machinery.
• Urease_Accessory_Pool (P75-P95): mildly elevated accessory urease support, which may facilitate urease maturation.
• BAI_Tyramine (P75-P95): mildly elevated tyramine-production potential.
• BAI_Putrescine (P75-P95): mildly elevated putrescine-production potential within the biogenic amine axis.
• ARI_Ammonia_Risk (P75-P95): mildly elevated composite ammonia-risk potential.
• Urease_Structural_Ratio (P75-P95): high structural colocalization efficiency, contextually consistent with a more organized urease system.
• MAOI_Contraindication_Flag (P75-P95): mild signal for tyramine-related caution within this functional profile.
• Hepatic_Encephalopathy_Risk_Flag (P75-P95): mild elevation of the urease-linked flag, reflecting the same high-normal ammonia axis rather than an extreme signal.

(b) BENEFICIAL in LOW band — REDUCED-SUPPORT direction.

• HAL_Histidase_Benefit (P5-P25): reduced beneficial routing of histidine toward glutamate/energy metabolism.

(c) WARNING / risk in LOW band — PROTECTIVE / favorable direction.

• BAI_Histamine (P5-P25): low histamine-production potential is favorable.
• UTPI_Uremic_Toxin_Production (P5-P25): a low toxic-to-beneficial tyrosine ratio is favorable and suggests relative containment of uremic-toxin pressure.
• Urease_Completeness_Ratio (P5-P25): a lower proportion of fully completed urease complexes is favorable in the context of ammonia burden.
• BAI_Histamine_Tyramine_Max (P5-P25): the dominant clinically relevant amine signal remains in a favorable low band.

(d) BENEFICIAL in HIGH band — STRENGTH / favorable direction.

• ArAT_Transaminase_Benefit (P75-P95): strong beneficial tyrosine transamination capacity supports diversion away from more toxic downstream routes.
• TBBI_Tyrosine_Bifurcation (P75-P95): favorable tyrosine bifurcation suggests the beneficial arm is relatively well preserved versus phenol/p-cresol/tyramine pathways.

Axis Convergence & Cross-Axis Interactions

The tyrosine axis is internally favorable overall: although TPL_Phenol_Risk is in P75-P95, the combination of ArAT_Transaminase_Benefit in P75-P95, TBBI_Tyrosine_Bifurcation in P75-P95, and UTPI_Uremic_Toxin_Production in P5-P25 suggests that beneficial routing still compares well against toxic routing at the systems level. This interpretation is supported by the fact that HpdBCA_pCresol_Total, HpdBCA_pCresol_Functional, and pCresol_Risk_Weighted all remain within IQR.

The urease → ammonia axis shows the clearest mild upward shift, with several urease metrics and ARI_Ammonia_Risk in P75-P95. However, this pattern is moderated by Urease_Full_Complex within IQR and a low Urease_Completeness_Ratio in P5-P25, which suggests that total urease potential is not matched by a disproportionately high share of fully completed complexes.

The biogenic amine axis is mixed rather than dominant: BAI_Tyramine and BAI_Putrescine are mildly elevated, while BAI_Histamine is favorably low and BAI_Total_Weighted remains within IQR. The histidine axis also appears buffered, because HAL_Histidase_Benefit is low but HBI_Histidine_Bifurcation stays within IQR, helped by the low histamine signal.

Composite Index Analysis

The composite picture is broadly balanced. UTPI_Uremic_Toxin_Production (P5-P25) is favorable, indicating that the ratio of phenol/p-cresol pathways to beneficial tyrosine transamination remains relatively contained; this appears to be supported by strong ArAT_Transaminase_Benefit and the absence of elevated p-cresol-weighted metrics.

TBBI_Tyrosine_Bifurcation (P75-P95) is also favorable and coherent with the same axis-level interpretation. In this case, the favorable direction is plausibly supported by high ArAT_Transaminase_Benefit together with only mild, not extreme, elevation of TPL_Phenol_Risk and BAI_Tyramine, while p-cresol metrics remain within IQR.

HBI_Histidine_Bifurcation, Beneficial_Pathways_Total, Detrimental_Pathways_Total, Protein_Metabolism_Balance, and PNTI_Protein_Nitrogen_Toxicity are all within IQR. That pattern argues against a globally shifted protein-fermentation profile and suggests that the mild urease and amine signals are not overwhelming the broader functional balance.

Clinical Picture (Functional Hypothesis)

This profile is most consistent with a balanced protein and nitrogen metabolism pattern with favorable tyrosine handling. The main strengths are ArAT_Transaminase_Benefit in P75-P95 and TBBI_Tyrosine_Bifurcation in P75-P95, which together suggest that tyrosine is relatively well directed toward a less toxic metabolic branch. This is reinforced by UTPI_Uremic_Toxin_Production in P5-P25, indicating a favorable toxic-to-beneficial ratio on the uremic-toxin axis.

The principal mild counterweight is a high-normal urease/ammonia signature, with several urease metrics and ARI_Ammonia_Risk in P75-P95. There is also a mixed biogenic amine pattern, where tyramine and putrescine are somewhat elevated but histamine remains favorably low. Overall, the basket does not suggest a dominant uremic-toxin-driven, ammonia-burdened, or biogenic-amine-dominant state; rather, it suggests a generally well-functioning profile with a few mild pathway skews worth longitudinal observation.

Within Normal Range (P25-P75)

The following metrics are within IQR and support an overall balanced functional profile:

• HpdBCA_pCresol_Total (P25-P50)
• HpdBCA_pCresol_Functional (P25-P50)
• pCresol_Risk_Weighted (P25-P50)
• Urease_Full_Complex (P25-P50)
• BAI_Cadaverine (P50-P75)
• TnaA_Indole_Production (P25-P50)
• GAD_GABA_Production (P50-P75)
• Phenol_pCresol_Combined_Risk (P25-P50)
• BAI_Total_Weighted (P50-P75)
• HBI_Histidine_Bifurcation (P50-P75)
• Beneficial_Pathways_Total (P50-P75)
• Detrimental_Pathways_Total (P50-P75)
• Protein_Metabolism_Balance (P25-P50)
• PNTI_Protein_Nitrogen_Toxicity (P50-P75)
• CKD_CVD_Risk_Flag (P25-P50)
• Histamine_Intolerance_Risk_Flag (P25-P50)

Clinical Correlation Considerations

• Routine monitoring is sufficient given the absence of extreme outliers in this basket.
• If clinically relevant symptoms are present, mild follow-up correlation could focus on ammonia-related burden (for example, bowel-pattern context or liver-related clinical background) because the urease axis is the main high-normal feature.
• If there is a history of MAOI use, tyramine sensitivity, or food-triggered symptoms, the mild elevation in tyramine-related potential may be worth contextual review, even though the overall basket remains balanced.

Interpretation Caveats

• This report reflects predicted functional potential from PICRUSt2, not direct measurement of phenol, p-cresol, ammonia, histamine, tyramine, GABA, or indole.
• Ratio-based indexes such as UTPI_Uremic_Toxin_Production, TBBI_Tyrosine_Bifurcation, and HBI_Histidine_Bifurcation depend on both numerator and denominator, so they should be interpreted together with their component pathways.
• Some metrics in this basket can use display caps in the reporting system; when capped, that indicates a true biological extreme above the clinical display scale, but raw uncapped values are intentionally not shown.
• The reference framework is a cohort of n=623; percentile bands describe relative position within that cohort, not an absolute diagnosis.
• Variation within a percentile band can still be biologically heterogeneous, so band placement is the primary interpretive grid.
• Composite indexes can mask offsetting strengths and liabilities; individual pathway review remains important, especially for the urease and biogenic amine axes.

Methodological Note

This report summarizes PICRUSt2-predicted functional potential of the gut microbiome, meaning it estimates what the microbiome could do based on inferred gene content from 16S data, rather than measuring actual neurotransmitter or metabolite concentrations. All findings are interpreted against a reference cohort of n=623 samples, using percentile bands as the primary normalization framework.

Several pathways in this basket are zero-inflated in the reference cohort, so an absent signal for some pathways can represent normal biology rather than deficiency. This is especially relevant for parts of the kynurenine branch and other conditionally detected functions.

Executive Summary

• This basket shows MINOR VARIATION, with a generally balanced neuromodulatory profile and only a small number of extreme findings requiring context rather than alarm.
• Tryptamine_Score is in P0-P1, indicating no detectable tryptamine-producing capacity in this sample; this is usually a neutral finding because this pathway is commonly low or absent in the cohort.
• Kyn_Neurotoxic is in P0-P1, which is a favorable pattern because it indicates no detectable neurotoxic kynurenine branch signal; at the same time, Kyn_Protective is detected and Kyn_Initiation is also present, supporting a more protective than neurotoxic kynurenine configuration.
• Outside the extreme findings, the profile also shows mild high-band support for GABA_Production, GABA_Shunt, and Neuromodulation_Risk, but these remain in the high-normal range rather than an extreme range.

Key Deviations (Outside P25-P75)

(a) WARNING / risk in HIGH band — UNFAVORABLE direction.

• GABA_Shunt (P75-P95): mildly increased GABA-consuming capacity, suggesting somewhat greater potential to use GABA as a substrate.
• Neuromodulation_Risk (P75-P95): mildly elevated aggregate risk signal, driven mainly by the combination of GABA consumption potential and ammonia-related contribution rather than by a neurotoxic kynurenine branch.

(b) BENEFICIAL in LOW band — REDUCED-SUPPORT direction.

• Tryptamine_Score (P0-P1): no detectable tryptamine-producing capacity; this reduces potential contribution to trace amine signaling and gut motility modulation, but is commonly neutral in this basket.
• Trp_Indole_Fraction (P5-P25): mildly lower indole-favored tryptophan partitioning relative to the cohort, suggesting somewhat less dominance of the indole branch despite preserved indole pathway capacity.

(c) WARNING / risk in LOW band — PROTECTIVE / favorable direction.

• Kyn_Neurotoxic (P0-P1): no detectable neurotoxic kynurenine branch signal, which is favorable because it avoids microbiome-encoded potential toward quinolinate-associated risk biology.

(d) BENEFICIAL in HIGH band — STRENGTH / favorable direction.

• GABA_Production (P75-P95): mildly increased GABA synthesis/export potential, supporting gut-brain signaling capacity.

Axis Convergence & Cross-Axis Interactions

The GABA axis is mixed but overall fairly balanced. GABA_Production and GABA_Shunt are both in P75-P95, while GABA_Net_Balance remains in P25-P50; this suggests that higher synthesis is accompanied by higher consumption, preventing a clear net GABA-favored shift.

The kynurenine state is best described as active-protective / non-neurotoxic: Kyn_Initiation is present, Kyn_Protective is present, and Kyn_Neurotoxic is absent. This is an important contextual pattern because it does not support a neurotoxic kynurenine interpretation.

The tryptophan branch shows preserved indole capacity in the interquartile range, but Trp_Indole_Fraction sits in P5-P25, indicating that the overall partitioning is only modestly indole-favored relative to the cohort. There is no high LPS_IDO1_Induction_Proxy signal here, so there is no functional basis in this basket for an LPS-driven host IDO1 induction hypothesis.

The ammonia/glutamate axis does not show a strong adverse signal: Glutamate_Ammonia_Risk is in P25-P50, so the mild elevation in Neuromodulation_Risk appears more related to aggregate weighting than to a distinct ammonia burden pattern.

Composite Index Analysis

Psychobiotic_Score is in P25-P50, which is compatible with an overall adequate psychobiotic functional profile rather than a strongly enriched one. This fits the broader picture: supportive elements are present, but they are partly offset by parallel GABA consumption and limited tryptamine contribution.

Neuromodulation_Risk is in P75-P95, representing a mild upward shift rather than an extreme risk pattern. Importantly, this composite should be interpreted alongside the individual components: the absence of Kyn_Neurotoxic substantially softens the meaning of this aggregate signal.

Clinical Picture (Functional Hypothesis)

The dominant functional pattern is a generally balanced neuromodulatory profile with selective strengths and a few mild asymmetries. The main supportive feature is high-normal GABA_Production, indicating preserved capacity for microbiome-encoded GABA synthesis/export. However, this is counterbalanced by similarly high-normal GABA_Shunt, so the net GABA picture is not strongly shifted in a favorable direction.

The tryptophan system appears non-neurotoxic and moderately supportive. Indole-related metrics are within the interquartile range, while the kynurenine branch shows a favorable configuration: initiation is detectable, protective capacity is detectable, and the neurotoxic branch is not detected. This argues against a microbiome pattern biased toward neurotoxic kynurenine metabolism.

The very low Tryptamine_Score indicates that this sample is unlikely to contribute meaningfully to tryptamine-mediated signaling. In isolation, that is usually not clinically important, but it does mean one potentially supportive neuromodulatory route is not prominent here.

Overall, this basket is most consistent with adequate gut-brain functional support without a major dysregulation signal, but also without a strongly enriched psychobiotic signature.

Within Normal Range (P25-P75)

The following metrics fall within the interquartile reference range or represent neutral detected states, supporting an overall stable functional background:

• GABA_Net_Balance (P25-P50)
• Indole_AhR (P25-P50)
• Indole_Pathway_Score (P25-P50)
• Kyn_Initiation (present / detected contextually; reported here as P75-P95 in source but functionally binary detection should be interpreted as presence rather than magnitude)
• Kyn_Protective (present / detected contextually; reported here as P75-P95 in source but functionally binary detection should be interpreted as presence rather than magnitude)
• Dopamine_Potential (P0-P1, low but neutral-context marker and not a major driver of this basket)
• Glutamate_Pool (P50-P75)
• Glutamate_Ammonia_Risk (P25-P50)
• Histamine (P5-P25, mild contextual variation)
• LPS_IDO1_Induction_Proxy (P25-P50)
• Psychobiotic_Score (P25-P50)

Clinical Correlation Considerations

• Routine clinical monitoring is sufficient if symptoms are stable; this basket does not show a major functional dysregulation pattern.
• If gut-brain symptoms are present, correlation may be most relevant with stress sensitivity, bowel motility patterns, and symptom fluctuation, given the combination of preserved GABA potential but absent tryptamine signal.
• If there is concern about inflammatory tryptophan diversion, this basket alone does not support that hypothesis strongly; host-side markers such as tryptophan/kynurenine ratio would only be worth considering if there are independent inflammatory clues.

Interpretation Caveats

• This is a report of predicted functional potential, not a direct measurement of GABA, indole, kynurenine metabolites, dopamine, or histamine levels.
• Binary scoring for the KYN pathway means that present and absent reflect detection status, not pathway magnitude.
• Display caps may apply to KYN metrics; if a value is at cap, that indicates a true biological extreme above the clinical display threshold, but the raw value is intentionally not shown.
• Kyn_Balance was deprecated in v5.7 because denominator-zero artifacts made it unreliable; it is not used in the main interpretation.
• The reference framework is based on a cohort of n=623 samples.
• Composite indexes can mask specific pathway details, so individual axis metrics remain more informative than the aggregate score alone.

Methodological Note

This report summarizes PICRUSt2-predicted metabolic potential from 16S-derived functional inference, interpreted against a reference cohort of n=623 samples. These findings describe what the microbiome could do functionally based on gene content, not direct stool or serum metabolite measurements.

All interpretations below are based on percentile bands within that cohort. In this basket, the pathways appear broadly active and comparable across the reference population, so percentile-based interpretation is appropriate.

Executive Summary

This basket is OPTIMAL, with a broadly balanced and well-functioning fermentation profile and no extreme outliers in the active percentile-scored metrics.

Two notable strengths are SCFA_Health_Score in P75-P95, suggesting supportive overall short-chain fatty acid balance, and Cross_Feeding_Efficiency in P75-P95, indicating robust acetate-to-butyrate cooperative potential. A further favorable feature is Lactate_to_Butyrate_Conversion in P75-P95, which supports efficient channeling of lactate into butyrate-producing routes rather than simple accumulation.

At the axis level, the pattern is consistent with good cross-feeding support: Total_Acetate_Production is in P75-P95 while Acetate_to_Butyrate_Ratio remains in P50-P75, which fits a balanced substrate supply without evidence of acetate trapping.

Key Deviations (Outside P25-P75)

No extreme outliers identified (no metrics in P0-P5 or P95-P99/P99-P100). The following findings are therefore mild, non-clinical variations outside the interquartile range.

(a) WARNING / risk in HIGH band — UNFAVORABLE direction.

• Mucin_Foraging_Risk (P75-P95): mild elevation suggests somewhat greater relative use of mucin-linked propionate sourcing; because Propanediol_Pathway_Propionate is also in P75-P95, this is worth contextual note rather than a standalone adverse signal.

(b) BENEFICIAL in LOW band — REDUCED-SUPPORT direction.

• (none)

(c) WARNING / risk in LOW band — PROTECTIVE / favorable direction.

• (none)

(d) BENEFICIAL in HIGH band — STRENGTH / favorable direction.

• Butyrate_CoA_Transferase_Potential (P75-P95): supportive terminal butyrate-forming capacity through the dominant CoA-transferase route, consistent with efficient acetate-supported butyrate generation.
• Total_Lactate_Production (P75-P95): mildly higher lactate throughput suggests active fermentation; because downstream detoxification and conversion markers are also elevated, this reads as productive turnover rather than accumulation.
• Acrylate_Pathway_Potential (P75-P95): supportive lactate-to-propionate conversion potential, which may help stabilize lactate handling.
• Lut_Pathway_Potential (P75-P95): supportive lactate-to-butyrate routing, consistent with productive reuse of lactate intermediates.
• Lactate_Detoxification_Ratio_Index (P75-P95): favorable detoxification balance; with Total_Lactate_Production in P75-P95 and D_Lactate_Risk_Score in P25-P50, this pattern is balanced rather than accumulation-prone.
• Succinate_Pathway_Propionate (P75-P95): supportive fiber-linked propionate production potential.
• Propanediol_Pathway_Propionate (P75-P95): mildly increased alternative propionate production from fucose/rhamnose-related substrates; this should be interpreted together with the concurrently strong succinate pathway rather than in isolation.
• Propionate_Production_Index (P75-P95): supportive overall propionate-producing capacity.
• Wood_Ljungdahl_Acetogenesis (P75-P95): supportive reductive acetogenesis potential, contributing to acetate availability.
• Total_Acetate_Production (P75-P95): robust acetate supply; with Acetate_to_Butyrate_Ratio in P50-P75, this fits adequate substrate availability without evidence of inefficient accumulation.
• Cross_Feeding_Efficiency (P75-P95): supportive acetate–butyrate cross-feeding potential, driven by elevated CoA-transferase capacity alongside solid acetate production.
• SCFA_Health_Score (P75-P95): favorable composite pattern consistent with supportive SCFA balance across the basket.
• Fermentation_Capacity_Index (P75-P95): robust overall fermentative throughput across SCFA-related pathways.
• Lactate_to_Butyrate_Conversion (P75-P95): supportive routing of lactate toward butyrate synthesis, aligning with the elevated Lut pathway.

Axis Convergence & Cross-Axis Interactions

The butyrate axis appears balanced-to-supportive: Butyrate_CoA_Transferase_Potential is in P75-P95, while Butyrate_Kinase_Potential, Butyrate_Core_Pathway, and Butyrate_Production_Index remain within the interquartile range. This suggests preserved butyrate capacity without evidence that the system is relying on a compensatory alternative pathway.

The acetate and cross-feeding axis is favorable. Total_Acetate_Production in P75-P95 together with Acetate_to_Butyrate_Ratio in P50-P75 fits a pattern of adequate acetate production with balanced conversion, rather than an acetate trap.

The lactate axis is also supportive: Total_Lactate_Production, Acrylate_Pathway_Potential, Lut_Pathway_Potential, Lactate_Detoxification_Ratio_Index, and Lactate_to_Butyrate_Conversion are all favorable, while D_Lactate_Risk_Score stays in the interquartile range. That combination is consistent with active lactate turnover and good downstream handling.

On the propionate axis, both Succinate_Pathway_Propionate and Propanediol_Pathway_Propionate are in P75-P95. Because the succinate route is also strong, this does not suggest a simple shift away from fiber-linked fermentation; rather, it indicates broad propionate-producing versatility.

Composite Index Analysis

SCFA_Health_Score in P75-P95 is a clear overall strength and supports the impression of a metabolically supportive SCFA profile. This composite is consistent with the preserved butyrate axis, favorable lactate detoxification balance, and good cross-feeding support.

Fermentation_Capacity_Index in P75-P95 indicates robust overall fermentative potential. In practical terms, the basket does not suggest a low-throughput fermentation pattern.

Mucin_Foraging_Risk in P75-P95 is the one mild cautionary composite signal. However, because Succinate_Pathway_Propionate is also in P75-P95, the pattern is better read as mixed propionate sourcing rather than a clear dominance of mucin-linked metabolism.

Clinical Picture (Functional Hypothesis)

The dominant functional pattern is a balanced fermentation ecosystem with strong SCFA support. The main drivers of that label are SCFA_Health_Score in P75-P95 and Cross_Feeding_Efficiency in P75-P95, supported by favorable lactate reutilization markers.

This profile suggests a microbiome with good potential to generate and interconvert major fermentation products rather than allowing them to accumulate inefficiently. In particular, the combination of elevated Lactate_to_Butyrate_Conversion and elevated Lactate_Detoxification_Ratio_Index supports a lactate-handling-efficient pattern.

The butyrate system appears functionally intact, with a supportive dominant terminal pathway and no sign of upstream-core/terminal mismatch. The acetate side also looks well integrated, because acetate supply is strong while the acetate-to-butyrate balance remains within the interquartile range.

Overall, this is most consistent with a well-buffered, fermentation-competent SCFA profile with only a mild contextual note around mucin-linked propionate contribution.

Within Normal Range (P25-P75)

The remaining metrics sit within the expected interquartile range, supporting an overall balanced functional profile.

• Butyrate_Kinase_Potential (P25-P50): within normal range.
• Butyrate_Core_Pathway (P50-P75): within normal range.
• Butyrate_Production_Index (P50-P75): within normal range.
• L_Lactate_Production (P50-P75): within normal range.
• D_Lactate_Production (P50-P75): within normal range.
• D_Lactate_Risk_Score (P25-P50): within normal range.
• AckA_Pta_Acetate_Production (P50-P75): within normal range.
• Acetate_to_Butyrate_Ratio (P50-P75): within normal range.
• Terminal_vs_Core_Butyrate_Ratio (P50-P75): within normal range.

Clinical Correlation Considerations

• Routine monitoring is sufficient; this basket does not suggest any urgent functional imbalance in carbohydrate fermentation or SCFA potential.
• If clinical context includes bloating or carbohydrate sensitivity, correlation with dietary fiber pattern and, if needed, a direct stool SCFA panel may help confirm whether predicted functional strengths translate into measured metabolite output.
• If there are barrier-related symptoms, the mild elevation in Mucin_Foraging_Risk could be interpreted alongside dietary substrate availability, especially habitual fermentable fiber intake.

Interpretation Caveats

• PICRUSt2 predicts functional potential, not actual metabolite concentrations. A favorable butyrate or propionate pathway signal does not guarantee that stool or serum SCFA levels are proportionally elevated.
• Ratio metrics depend on both numerator and denominator. This is especially relevant for Acetate_to_Butyrate_Ratio, Lactate_Detoxification_Ratio_Index, and Terminal_vs_Core_Butyrate_Ratio.
• Composite indexes can mask internal variation. SCFA_Health_Score and Fermentation_Capacity_Index are useful summaries, but individual pathway metrics remain important for interpretation.
• Reference framework: all percentile bands are relative to a cohort of n=623 samples.
• Variation within a percentile band is expected. Metrics in the same band may still differ numerically, but the band itself is the clinically relevant normalization frame used here.

Methodological Note

This report summarizes PICRUSt2-predicted functional potential, meaning it estimates what the microbiome could do based on inferred gene content from 16S-derived profiles, rather than measuring actual LPS, curli, amyloid, or biofilm activity directly. Results are interpreted against a reference cohort of n=623 samples, using percentile bands as the primary normalization framework.

In this basket, interpretation is based on percentile position within the cohort and applies only to the functional domains covered here: LPS/lipid A structure, curli/amyloid potential, and biofilm/adhesion/UTI-related traits.

Executive Summary

• This basket shows an OPTIMAL overall status: there are no unfavorable extreme outliers, although several metrics sit in P75-P95 and one balance metric is in P5-P25, which represents mild variation rather than a major imbalance.
• The most favorable finding is Immune_Evasion_vs_Activation_Ratio in P5-P25, which suggests a relatively activation-leaning rather than stealth-dominant balance on the LPS immune-signaling axis.
• A second favorable feature is the absence of any high-extreme signal in the major composite warning indices: despite several being in P75-P95, none reach the extreme bands that would indicate a clearly dysregulated proinflammatory, amyloid, biofilm, or uropathogenic-trait pattern.
• Overall, this profile is best read as a broadly controlled functional state with mild upward clustering across several warning metrics, but without the degree of deviation that would shift the basket out of the optimal category.

Key Deviations (Outside P25-P75)

(a) WARNING / risk in HIGH band — UNFAVORABLE direction.

• TLR4_High_LPS_Index (P75-P95): mildly elevated relative positioning suggests somewhat higher potential for strongly immunogenic, TLR4-activating LPS signaling, but still not an extreme outlier.
• Stealth_LPS_Index (P75-P95): mildly higher stealth-type lipid A modification potential is present, which is contextual rather than a standalone adverse finding.
• LPS_Immunogenic_Balance (P75-P95): mild upward shift indicates a tendency toward a more immunogenic LPS balance rather than a stealth-dominant orientation.
• Curli_Operon_Completeness (P75-P95): mildly increased curli operon completeness suggests somewhat greater structural capacity for curli-associated amyloid formation.
• Curli_Active_Production (P75-P95): mildly increased active curli-production potential suggests somewhat higher capacity for curli fiber assembly.
• Amyloid_Risk_Index (P75-P95): mild upward variation indicates somewhat increased predicted amyloid-forming potential, without reaching an extreme band.
• Biofilm_Formation_Index (P75-P95): mild upward variation suggests somewhat greater overall biofilm-formation potential.
• Adhesion_Potential_Index (P75-P95): mildly increased adhesion-trait potential suggests somewhat greater surface attachment capacity.
• UTI_Risk_Index (P75-P95): mild upward variation suggests somewhat higher uropathogenic-trait potential in functional terms, without implying active infection.
• Pathogenic_E_coli_Markers (P75-P95): mild upward variation in this uropathogenic-trait marker composite suggests somewhat increased pathogenic surface-trait potential; this does not indicate detection of a specific species.
• Proinflammatory_Surface_Score (P75-P95): mildly increased integrated surface-structure inflammatory potential is present, but not in an extreme band.
• Gram_Negative_Pathogenic_Potential (P75-P95): mild upward variation suggests somewhat higher combined gram-negative pathogenic-trait potential, still below extreme-outlier range.

(b) BENEFICIAL in LOW band — REDUCED-SUPPORT direction.

(none)

(c) WARNING / risk in LOW band — PROTECTIVE / favorable direction.

• Immune_Evasion_vs_Activation_Ratio (P5-P25): low-band positioning is favorable here, suggesting the profile is less shifted toward stealth-dominant immune evasion and more weighted toward activation-side balance.

(d) BENEFICIAL in HIGH band — STRENGTH / favorable direction.

(none)

Axis Convergence & Cross-Axis Interactions

• AXIS 1 — LPS burden / gram-negative potential: HIGH=1 (Gram_Negative_Pathogenic_Potential P75-P95), LOW=0; Lipid_A_Biosynthesis_Potential remains in P25-P50. Conclusion: mild upward composite shift without baseline lipid A biosynthesis elevation.
• AXIS 2 — TLR4-High / proinflammatory: HIGH=3 (TLR4_High_LPS_Index P75-P95, LPS_Immunogenic_Balance P75-P95, Proinflammatory_Surface_Score P75-P95), LOW=0; Hexa_Acyl_Total_Potential is in P50-P75. Conclusion: the main directional tendency is a mild immunogenic/proinflammatory tilt, but without extreme convergence.
• AXIS 3 — Stealth / immune evasion: HIGH=1 (Stealth_LPS_Index P75-P95), LOW=1 (Immune_Evasion_vs_Activation_Ratio P5-P25). Conclusion: mixed stealth-axis pattern, with some stealth-capacity signal but no stealth-dominant overall ratio.
• AXIS 4 — Curli / amyloid: HIGH=3 (Curli_Operon_Completeness P75-P95, Curli_Active_Production P75-P95, Amyloid_Risk_Index P75-P95), LOW=0. Conclusion: mild internal convergence toward higher curli/amyloid potential, though still short of extreme dysregulation.
• AXIS 5 — Biofilm / adhesion / UTI: HIGH=4 (Biofilm_Formation_Index P75-P95, Adhesion_Potential_Index P75-P95, UTI_Risk_Index P75-P95, Pathogenic_E_coli_Markers P75-P95), LOW=0. Conclusion: this is the clearest area of mild upward clustering, consistent with somewhat increased surface-attachment and biofilm-related functional potential.

Composite Index Analysis

• TLR4_High_LPS_Index and Proinflammatory_Surface_Score are both in P75-P95, which supports a mild upward shift in predicted inflammatory surface signaling.
• LPS_Immunogenic_Balance in P75-P95 suggests the LPS profile leans more immunogenic than stealth-weighted at the balance level.
• Biofilm_Formation_Index, Adhesion_Potential_Index, and UTI_Risk_Index all sit in P75-P95, indicating coherent but still mild elevation across the biofilm/attachment/urodynamic trait composites.
• Pathogenic_E_coli_Markers is also in P75-P95; this should be read strictly as a uropathogenic-trait composite signal, not as evidence of species detection.
• Immune_Evasion_vs_Activation_Ratio in P5-P25 partially offsets the higher Stealth_LPS_Index, arguing against a strongly stealth-dominant interpretation.

Clinical Picture (Functional Hypothesis)

• The dominant pattern is a mildly upward-shifted surface-structure profile, spanning immunogenic LPS signaling, curli-related amyloid potential, and biofilm/adhesion traits.
• The most coherent clustering is in the biofilm/adhesion/UTI axis, where multiple related warning metrics fall in P75-P95, suggesting somewhat increased capacity for persistence-oriented surface behavior.
• The TLR4-high/proinflammatory axis is also mildly shifted upward, but without extreme outliers; functionally, this suggests a tendency rather than a strongly dysregulated inflammatory signature.
• The stealth axis is mixed rather than dominant: Stealth_LPS_Index is mildly high, but Immune_Evasion_vs_Activation_Ratio is low-band, which does not support a clear immune-evasion-heavy profile.

Within Normal Range (P25-P75)

• Lipid_A_Biosynthesis_Potential (P25-P50): within the normal reference range, indicating baseline lipid A biosynthetic capacity is not shifted upward.
• Hexa_Acyl_Total_Potential (P50-P75): within the normal reference range, indicating total hexa-acylation potential remains broadly typical relative to the cohort.

Clinical Correlation Considerations

• This profile does not show extreme dysregulation in the LPS, curli/amyloid, or biofilm-related domains; correlation should therefore be conservative and symptom-led rather than assumption-led.
• If there is relevant clinical context, the mild upward clustering is most logically correlated with surface-structure persistence traits rather than with a sharply inflammatory or stealth-dominant pattern.

Interpretation Caveats

• This is a report of predicted gene potential, not a direct measurement of actual LPS production, lipid A structure, biofilm formation, curli assembly, or amyloid activity.
• No direct measurement of LPS burden, biofilm biomass, curli fibers, or amyloid material is provided here.
• Immune_Evasion_vs_Activation_Ratio has an application display cap of 1000; when capped, it should be interpreted as being at the upper clinical scale. In this sample, no cap-related issue is evident from the provided data.
• Pathogenic_E_coli_Markers is a uropathogenic-trait marker composite; its technical name does not imply detection of a specific species.
• The reference framework is a cohort of n=623 samples; percentile bands reflect relative position within that cohort, not absolute pathology thresholds.
• Variation within and between percentile bands is expected, and no causal inference should be made from this basket alone.

Methodological Note

This report interprets PICRUSt2-predicted metabolic potential, meaning the microbiome’s inferred functional capacity based on 16S-derived gene content rather than direct measurement of TMA, TMAO, choline metabolites, or cardiovascular biomarkers. Results are expressed as percentile bands versus a reference cohort of n=623 samples.

Several pathways in this basket are relatively sparse in the reference cohort, so for some markers an absent signal can be normal biology; however, in this case the main interpretation is driven by the percentile-positioned active pathways and balance indices.

Executive Summary

• Basket status: SIGNIFICANT DYSREGULATION. This basket contains 11 extreme outliers, indicating a functionally important imbalance across TMA production, protective diversion, and clearance/sink capacity.
• Assigned pattern: Multi-Axis Risk Profile with Sink-Deficient and Kennedy-Deficit features. The strongest drivers are MttB_TMA_Clearance in P0-P1, TMA_Sink_Potential in P0-P1, TMA_SINK_ACTIVE_FLAG in P0-P1, and Kennedy protection metrics in P5-P25, indicating weak buffering of TMA once generated.
• On the production side, the profile is not globally extreme, but it is tilted upward: CutC_TMA_Production, TMAO_Reductase_Recycling, TMA_Production_Risk_Index, TMA_Net_Balance, TMAO_Amplification_Risk, and CVD_Risk_Composite_Score are all in P75-P95, which together suggests a production-plus-amplification pattern occurring without adequate compensatory sink activity.

Key Deviations (Outside P25-P75)

(a) WARNING / risk in HIGH band — UNFAVORABLE direction.

• CutC_TMA_Production (P75-P95): mildly elevated anaerobic choline-to-TMA potential, suggesting greater routing of choline toward TMA generation.
• TMAO_Reductase_Recycling (P75-P95): mildly elevated TMAO-to-TMA recycling potential, which may support recirculation/amplification of the TMA/TMAO pool.
• TMA_Production_Risk_Index (P75-P95): production-to-protection ratio is shifted upward, driven by relatively stronger production pressure than Kennedy buffering.
• TMA_Net_Balance (P75-P95): net balance is production-shifted, consistent with insufficient compensation from sink plus protective diversion.
• TMAO_Amplification_Risk (P75-P95): amplification composite is mildly elevated, mainly reflecting the combination of TMAO recycling with non-low total production.
• CVD_Risk_Composite_Score (P75-P95): composite cardiovascular-metabolic signal is shifted upward, driven by the combined effect of CutC activity, amplification, and weak clearance buffering.

(b) BENEFICIAL in LOW band — REDUCED-SUPPORT direction.

• Kennedy_CCT_Enzyme (P5-P25): lower protective phosphocholine-to-CDP-choline capacity, suggesting weaker anabolic diversion of choline away from TMA formation.
• Kennedy_Pathway_Total (P5-P25): lower overall Kennedy pathway support, indicating reduced choline trapping into phospholipid synthesis.
• MttB_TMA_Clearance (P0-P1): extremely low TMA-specific clearance potential, indicating minimal direct sink activity for TMA removal.
• TMA_Sink_Potential (P0-P1): extremely low overall sink capacity, driven by absent/near-absent clearance components.
• Choline_Bifurcation_Index (P5-P25): bifurcation is shifted away from Kennedy protection and toward TMA-producing routing, driven by low Kennedy_Pathway_Total relative to CutC_TMA_Production.
• Kennedy_Protection_Score (P5-P25): reduced net protective effect of the Kennedy axis relative to CutC pressure.
• Clearance_Compensation_Ratio (P0-P1): clearance does not compensate for production, driven by very low TMA_Sink_Potential against non-low Total_TMA_Production_Potential.
• KENNEDY_PROTECTIVE_FLAG (P5-P25): protective Kennedy-pattern support is weak rather than dominant.
• TMA_SINK_ACTIVE_FLAG (P0-P1): active TMA sink signal is effectively absent, matching the very low MttB_TMA_Clearance result.

(c) WARNING / risk in LOW band — PROTECTIVE / favorable direction.

(none)

(d) BENEFICIAL in HIGH band — STRENGTH / favorable direction.

• TMA_Clearance_Balance (P75-P95): this balance index sits high because production dominates over clearance; despite the metric name, the driving pattern here is very low sink relative to ongoing production, which is consistent with the broader clearance-deficient picture.

Axis Convergence & Cross-Axis Interactions

The most coherent cross-axis signal is a production-without-compensation pattern. Total production is not in an extreme band, but the system is still pushed toward higher TMA burden because clearance/sink capacity is profoundly weak while several production-related and amplification-related markers sit above the interquartile range.

The anaerobic choline axis appears more relevant than the aerobic carnitine axis here. CutC_TMA_Production is in P75-P95, whereas CntA_Raw_Potential, CntB_Reductase_Component, and CntAB_Functional_System remain in P50-P75. This supports a more choline-responsive than carnitine-dominant orientation.

The Kennedy protection axis does not adequately buffer this. Although Kennedy_Choline_Kinase is in P25-P50, the downstream protective architecture is weaker overall because Kennedy_CCT_Enzyme and Kennedy_Pathway_Total are both in P5-P25. That pattern is consistent with incomplete or underpowered diversion of choline into phospholipid synthesis.

The clearance/sink axis is the clearest vulnerability. MttB_TMA_Clearance, TMA_Sink_Potential, and TMA_SINK_ACTIVE_FLAG are all in P0-P1, and Clearance_Compensation_Ratio is also in P0-P1. Functionally, this suggests that once TMA is generated, the microbiome shows very limited capacity to neutralize or consume it before host conversion pathways become relevant.

The amplification axis adds to this burden. TMAO_Reductase_Recycling and TMAO_Amplification_Risk are both in P75-P95, which may favor recycling of TMAO back into TMA and sustain the broader TMA/TMAO loop.

Flag concordance is partial rather than complete: HIGH_TMA_RISK_FLAG and CARNITINE_TMA_RISK_FLAG are in P50-P75, so the profile is not a maximal production phenotype. Instead, the dominant issue is that moderately elevated production pressure is paired with markedly weak protective and sink mechanisms.

Composite Index Analysis

TMA_Production_Risk_Index (P75-P95) is shifted upward, indicating that production pressure exceeds Kennedy-mediated protection. This direction is supported by CutC_TMA_Production in P75-P95 together with Kennedy_Pathway_Total in P5-P25.

TMA_Net_Balance (P75-P95) is also production-shifted. The main driver is not extreme total production, but rather the denominator side: TMA_Sink_Potential in P0-P1 plus Kennedy_Pathway_Total in P5-P25 provide limited counterweight.

TMAO_Amplification_Risk (P75-P95) is elevated in parallel with TMAO_Reductase_Recycling in P75-P95, indicating that amplification contributes meaningfully to the overall pattern.

Kennedy_Protection_Score (P5-P25) is reduced, consistent with insufficient anabolic diversion of choline relative to CutC-associated pressure.

Clearance_Compensation_Ratio (P0-P1) indicates that sink activity is not compensating for production. This is concordant with MttB_TMA_Clearance in P0-P1 and TMA_Sink_Potential in P0-P1.

CVD_Risk_Composite_Score (P75-P95) is mildly elevated as an integrated signal. Its direction is supported by the combination of CutC_TMA_Production, TMA_Production_Risk_Index, TMAO_Amplification_Risk, and the broader clearance-deficient context.

Clinical Picture (Functional Hypothesis)

This profile is most consistent with a Multi-Axis Risk Profile centered on sink deficiency and reduced Kennedy protection, with a secondary contribution from mildly elevated choline-linked production and TMAO recycling. The microbiome does not show a uniformly extreme production phenotype across all substrates, but it appears poorly equipped to buffer or clear TMA once formed.

The likely dominant source is the anaerobic choline-to-TMA route, because CutC_TMA_Production is above the interquartile range while the carnitine-linked system remains within P50-P75. At the same time, the Kennedy pathway is underpowered, so less choline may be diverted into phospholipid synthesis. This is reinforced by the low Choline_Bifurcation_Index, which points toward a less favorable partitioning of choline.

The most important functional limitation is the near-absent sink axis. With MttB_TMA_Clearance, TMA_Sink_Potential, and TMA_SINK_ACTIVE_FLAG all in P0-P1, there is little evidence of meaningful microbiome-level TMA consumption. In that setting, even moderately increased production pressure can translate into a more unfavorable net balance.

The amplification layer further strengthens this interpretation. Elevated TMAO_Reductase_Recycling and TMAO_Amplification_Risk suggest that recycling dynamics may help sustain the TMA/TMAO pool rather than dampen it.

Overall, this is not a “maximal producer” pattern; it is better described as a poorly buffered TMA metabolism profile, where limited clearance and weak protective diversion allow modest-to-moderately elevated production signals to carry greater functional relevance.

Within Normal Range (P25-P75)

The following markers are within the interquartile range or otherwise neutral/non-applicable, indicating areas without a strong functional signal in this basket:

• CntA_Raw_Potential (P50-P75)
• CntB_Reductase_Component (P50-P75)
• CntAB_Functional_System (P50-P75)
• Betaine_Reductase_TMA (P25-P50)
• Total_TMA_Production_Potential (P50-P75)
• Kennedy_Choline_Kinase (P25-P50)
• Carnitine_Diet_Risk (P50-P75)
• CntAB_Aerobic_TMAO_Index (P50-P75)
• HIGH_TMA_RISK_FLAG (P50-P75)
• CARNITINE_TMA_RISK_FLAG (P50-P75)
• Methylamine_Clearance_Extended: not detected / neutral in isolation for a zero-inflated pathway.

Clinical Correlation Considerations

• Consider correlating this pattern with cardiometabolic context, especially standard lipid markers and, if clinically relevant, inflammatory markers such as hsCRP.
• If there is concern about systemic accumulation, renal context may matter; reduced renal clearance can influence downstream TMAO handling independently of microbiome production.
• A focused dietary review may be useful, particularly around choline-rich foods and overall substrate exposure that could feed the CutC-linked axis.
• Where available, direct TMAO or related metabolite measurement could help confirm whether this predicted functional pattern translates into measurable host exposure.
• Host FMO3 variation remains clinically relevant, because hepatic conversion of TMA to TMAO can differ independently of microbial production potential.

Interpretation Caveats

• This analysis reflects predicted functional potential, not direct measurement of circulating or luminal TMA / TMAO.
• FMO3 host genetics can substantially modulate plasma TMAO independently of microbial TMA production capacity.
• Several B07 metrics use display caps (including CVD_Risk_Composite_Score, MttB_TMA_Clearance, TMA_Sink_Potential, Choline_Bifurcation_Index, TMA_Production_Risk_Index, TMA_Net_Balance, TMA_SINK_ACTIVE_FLAG, Clearance_Compensation_Ratio, and Methylamine_Clearance_Extended). If a value is capped, that indicates a true biological extreme above the display threshold; raw values are intentionally not shown.
• Composite indices should always be interpreted together with their component metrics rather than in isolation.
• The reference framework is a cohort of n=623 samples; interpretation is relative to that population, not an absolute biochemical cutoff.
• Variation within percentile bands is expected, and this report does not imply causality or diagnosis.
• Some pathways in this basket are zero-inflated in the reference population, so absence of a sparse pathway may represent normal biology rather than dysfunction.

Methodological Note

This report reflects PICRUSt2-predicted metabolic potential derived from 16S-based gene content, not direct measurement of H₂S or sulfur metabolites. Results are interpreted as percentile bands versus a reference cohort of n=623, so the report describes what this microbiome could be capable of functionally. Several pathways in this basket are zero-inflated in the reference cohort, so an absent signal for those pathways can represent normal biology rather than a deficit.

Executive Summary

• This sulfur-metabolism basket shows SIGNIFICANT DYSREGULATION by outlier count, but the pattern is Mixed rather than uniformly production-heavy.
• A strongly protective feature is the near-complete suppression of core dissimilatory sulfate-reduction machinery: DsrAB_Total_Activity, DsrAB_Functional_Colocalized, DsrA_Subunit_Total, DsrB_Subunit_Total, DsrABC_Full_Module_Potential, and SRB_Full_Pathway_Potential are all in P0-P1, which is consistent with minimal canonical terminal sulfate-to-H₂S reduction capacity.
• At the same time, several upstream sulfate-reduction and composite production markers are shifted upward, including AprAB_Total_Activity, AprAB_Functional_Colocalized, Sat_Potential, SAI_SRB_Activity_Index, H2S_Production_Total, and HPRI_H2S_Production_Risk_Index in P75-P95, while SMB_Sulfur_Metabolism_Balance is in P5-P25, indicating a production-leaning balance despite absent terminal DsrAB output.
• Detoxification is partly buffered but incomplete: SQR_Potential, Detox_Potential_Total, and SDI_Sulfur_Detoxification_Index remain in P50-P75, whereas Sox_System_Potential is not detected, so sulfur oxidation support appears present through SQR but not through the Sox route.

Key Deviations (Outside P25-P75)

(a) WARNING / PRODUCTION / RISK in HIGH band — UNFAVORABLE direction.

• DsrC_Accessory_Potential (P75-P95): elevated accessory electron-transfer support is worth noting, although it is not accompanied here by active colocalized DsrAB terminal machinery.
• AprAB_Total_Activity (P75-P95): increased upstream APS-reduction potential may support sulfate-reduction flow toward sulfite generation.
• AprAB_Functional_Colocalized (P75-P95): higher colocalized AprAB signal suggests a relatively intact upstream APS-reduction module.
• AprAB_Coloc_Ratio (P75-P95): high colocalization ratio supports functional coherence of the AprAB step.
• AprA_Subunit_Total (P75-P95): increased AprA abundance is consistent with stronger upstream sulfate activation/reduction capacity.
• AprB_Subunit_Total (P75-P95): increased AprB abundance further supports the same upstream sulfate-reduction tendency.
• Sat_Potential (P75-P95): elevated sulfate activation capacity suggests readiness to channel sulfate into APS-dependent pathways.
• SAI_SRB_Activity_Index (P75-P95): the composite SRB-oriented activity index is high-normal, indicating upward pressure from sulfate-reduction components despite absent terminal DsrAB output.
• H2S_Production_Total (P75-P95): total modeled H₂S-production potential is shifted upward, driven more by composite weighting of upstream sulfate-reduction and protein-fermentation contribution than by terminal DsrAB completion.
• HPRI_H2S_Production_Risk_Index (P75-P95): the production-to-safe-assimilation risk ratio is high-normal, suggesting relatively greater modeled production pressure versus assimilation buffering.
• SMB_Sulfur_Metabolism_Balance (P5-P25): low sulfur-metabolism balance indicates a production-dominant orientation relative to detoxification/assimilation support.

(b) BENEFICIAL / DETOX in LOW band — REDUCED-SUPPORT direction.

• (none)

(c) WARNING / PRODUCTION / RISK in LOW band — PROTECTIVE / favorable direction.

• DsrAB_Total_Activity (P0-P1): extremely low terminal dissimilatory sulfite-reduction potential is favorable and suggests minimal canonical sulfate-to-H₂S generation.
• DsrAB_Functional_Colocalized (P0-P1): extremely low colocalized active DsrAB signal is favorable and argues against a functionally assembled terminal SRB module.
• DsrA_Subunit_Total (P0-P1): extremely low DsrA support is favorable and consistent with minimal terminal sulfate-reduction machinery.
• DsrB_Subunit_Total (P0-P1): extremely low DsrB support is favorable and consistent with minimal terminal sulfate-reduction machinery.
• DsrABC_Full_Module_Potential (P0-P1): extremely low full-module potential is favorable and argues against a complete DsrABC terminal complex.
• SRB_Full_Pathway_Potential (P0-P1): extremely low full-pathway SRB potential is favorable and suggests little evidence for a complete canonical sulfate-reducing H₂S-production route.

(d) BENEFICIAL / DETOX in HIGH band — STRENGTH / favorable direction.

• Sulfite_Reductase_Total_Activity (P75-P95): higher assimilatory sulfite-reduction capacity suggests a relatively robust safe sulfur-assimilation reserve.
• Sulfite_Reductase_Functional_Colocalized (P75-P95): higher colocalized assimilatory reductase signal supports functional completeness of the safe assimilation route.
• Sulfite_Reductase_Coloc_Ratio (P75-P95): high colocalization ratio supports efficient assembly of the assimilatory sulfite-reduction step.
• CysI_Subunit_Total (P75-P95): increased CysI support is consistent with stronger assimilatory sulfite-reduction capacity.
• CysJ_Subunit_Total (P75-P95): increased CysJ support complements the same safe-assimilation pathway.
• IscS_Tpa_Sulfur_Trafficking_Potential (P75-P95): higher sulfur-trafficking potential suggests preserved sulfur handling and transfer functions rather than free H₂S release.

Axis Convergence & Cross-Axis Interactions

The most important cross-axis feature is the discordance within the sulfate-reduction axis. The terminal DsrAB arm is strongly suppressed, with multiple core DsrAB metrics in P0-P1, yet the upstream activation/reduction steps Sat_Potential and the AprAB family are in P75-P95. Functionally, this suggests that sulfate-processing capacity is present, but the final canonical conversion step to H₂S through the DsrAB route appears poorly supported.

The protein-fermentation H₂S source does not show a parallel upward shift: PFHI_Protein_Fermentation_H2S_Index is in P50-P75, so this basket does not point to a dominant protein-putrefaction H₂S pattern. That makes the elevated production composites more likely to reflect weighting from the upstream sulfate-reduction side rather than broad convergence of both major H₂S-producing routes.

On the detoxification side, SQR_Potential and Detox_Potential_Total are in P50-P75, which is adequate but not unusually strong. Sox_System_Potential is not detected, so the Sox oxidation route is simply unavailable in this sample; given the zero-inflated reference distribution, that is a common cohort pattern and should not be overinterpreted as a defect. The low SMB_Sulfur_Metabolism_Balance indicates that, despite preserved SQR-based buffering and good assimilatory reserve, the overall modeled balance still tilts toward production-side pressure.

Composite Index Analysis

H2S_Production_Total is in P75-P95, indicating elevated modeled production potential. In this sample, that direction appears to be driven mainly by SAI_SRB_Activity_Index in P75-P95, while PFHI_Protein_Fermentation_H2S_Index remains in P50-P75; therefore, the composite is not being pushed by strong protein-fermentation excess.

HPRI_H2S_Production_Risk_Index is also in P75-P95, meaning the production-to-safe-assimilation ratio is shifted upward. This occurs despite SAI_Safe_Sulfur_Assimilation_Index in P50-P75, so the risk signal reflects production pressure outpacing assimilation reserve rather than a collapse of assimilation.

SMB_Sulfur_Metabolism_Balance is in P5-P25, which indicates a less favorable production-versus-protection balance. The main drivers are H2S_Production_Total in P75-P95 against only P50-P75 detox support from Detox_Potential_Total and SDI_Sulfur_Detoxification_Index.

Detox_Potential_Total and SDI_Sulfur_Detoxification_Index remain in P50-P75, so detoxification is present and moderately supportive. Their direction is mainly carried by SQR_Potential in P50-P75, while Sox_System_Potential is not detected and Sox_Coloc_Ratio is not meaningfully supportive here.

Clinical Picture (Functional Hypothesis)

This pattern is most consistent with a Mixed sulfur-metabolism profile. On one side, there is a clearly favorable suppression of the canonical terminal DsrAB-dependent sulfate-to-H₂S route, supported by multiple P0-P1 findings across the DsrAB family and SRB_Full_Pathway_Potential. On the other side, several upstream sulfate-processing markers and production-oriented composites are shifted upward into P75-P95, so the basket does not read as globally quiet.

Functionally, this may indicate a microbiome with active sulfur handling and upstream sulfate activation but limited completion of the classic terminal H₂S-generating SRB module. Because PFHI_Protein_Fermentation_H2S_Index stays within P50-P75, the data do not strongly support excessive protein-fermentation H₂S as the main driver. Detoxification appears adequate but not dominant, with preserved SQR_Potential but no detected Sox_System_Potential. The low SMB_Sulfur_Metabolism_Balance therefore reflects an overall modeled system that leans toward production pressure more than protection, even though one major terminal production route is strongly muted.

In practical functional terms, this is not a simple “high H₂S producer” signature, nor a fully buffered low-production pattern. It is better understood as internally discordant sulfur metabolism: strong protection against one canonical route, but enough upstream and composite activity to keep the overall balance from looking fully controlled.

Within Normal Range (P25-P75)

The following metrics are within the interquartile range or are neutral non-applicable detections/non-detections, indicating preserved baseline sulfur-handling functions.

• CysK_CysM_Cysteine_Synthase_Potential (P25-P50): typical cysteine-synthesis potential.
• PFHI_Protein_Fermentation_H2S_Index (P50-P75): typical-to-upper-normal protein-fermentation H₂S potential.
• Detox_Potential_Total (P50-P75): adequate overall detoxification support.
• SQR_Potential (P50-P75): adequate sulfide oxidation capacity through SQR.
• SAI_Safe_Sulfur_Assimilation_Index (P50-P75): adequate composite safe-assimilation reserve.
• SDI_Sulfur_Detoxification_Index (P50-P75): adequate detoxification relative to modeled production.
• Sox_System_Potential (absent / binary not detected): Sox sulfur-oxidation system not detected; this is a common zero-inflated cohort pattern and is neutral in isolation.
• Sox_Coloc_Ratio: with Sox not detected, Sox colocalization is not interpretable as a meaningful low signal in this sample.

Clinical Correlation Considerations

• Correlate with symptoms that may reflect sulfur handling imbalance, such as bloating, sulfur-sensitive food intolerance, altered stool odor, or postprandial discomfort, while recognizing that this report does not measure actual H₂S.
• If sulfur sensitivity is clinically suspected, dietary context may help interpretation, especially sulfate/sulfur load and animal-protein intake, because the composite production signal is elevated even though terminal DsrAB completion is low.
• If available, consider orthogonal confirmation with a stool H₂S-related assay or sulfur breath testing, particularly when symptoms are disproportionate to standard stool findings.
• The discordance between upstream sulfate-reduction markers and terminal DsrAB suppression is worth following over time rather than interpreting from a single snapshot alone.
• Because detoxification is adequate but not dominant, repeat testing may be useful if symptoms change with diet, bowel habit, or inflammatory context.

Interpretation Caveats

• This analysis reflects predicted functional potential from PICRUSt2, not direct measurement of H₂S concentration, sulfur flux, or enzyme activity in vivo.
• Composite indices such as H2S_Production_Total, HPRI_H2S_Production_Risk_Index, and SMB_Sulfur_Metabolism_Balance should always be interpreted alongside their component metrics, because composite direction can mask internal discordance.
• Sox_System_Potential is a binary metric: detected vs not detected. It should not be interpreted as a graded “very high” or “very low” percentile signal.
• Sox_Coloc_Ratio is a ratio_conditional metric; when the Sox denominator is effectively absent, the ratio is not clinically interpretable as a true low colocalization state.
• The reference framework is a cohort of n=623 samples; percentile bands describe relative position within that cohort, not absolute pathology thresholds.
• Percentile placement does not imply causality, diagnosis, or direct symptom generation; individual physiology, diet, transit time, and host detoxification all influence real-world sulfur biology.

Methodological Note

This report summarizes PICRUSt2-predicted functional potential for basket B08, not direct biochemical activity in vivo. All findings are interpreted relatively against a reference cohort of n=623 samples, using percentile bands rather than absolute clinical cutoffs. Several pathways in this basket are zero-inflated in the reference cohort, so an absent signal can be normal biology in population terms.

Executive Summary

• This basket shows an OPTIMAL overall pattern with balanced oxalate handling; there are no extreme outliers in the unfavorable direction, and the dominant signal is protective.
• Type2_FullModule_Coloc in P99-P100 suggests very strong representation of the fully assembled Type II oxalate-degradation module, which is the most functionally supportive configuration in this basket.
• OI index in P99-P100 supports a strong specialised oxalate-degradation signature, while Oxalate_Stone_Risk_Index in P5-P25 is favorable and indicates a low composite stone-risk signal relative to the cohort.
• The broader pattern is coherent: Type II core and modular metrics are high, DPR_Degradation_Production_Ratio is in P75-P95, and the synthesis axis is not elevated.

Key Deviations (Outside P25-P75)

No extreme unfavorable outliers were identified. The non-IQR findings below are mostly protective strengths or mild favorable variation.

(a) WARNING / Pro-oxalate / risk in HIGH band — UNFAVORABLE direction.

• (none)

(b) BENEFICIAL / PROTECTIVE in LOW band — REDUCED-SUPPORT direction.

• (none)

(c) WARNING / Pro-oxalate / risk in LOW band — PROTECTIVE / favorable direction.

• Oxalate_Stone_Risk_Index (P5-P25): favorable low composite stone-risk signal, consistent with stronger degradation relative to pro-oxalate pressure.

(d) BENEFICIAL / PROTECTIVE in HIGH band — STRENGTH / favorable direction.

• Type2_OXC_total (P95-P99): strong Type II OXC core capacity, supporting efficient oxalate-degradation potential.
• Type2_FRC_total (P75-P95): mildly high Type II FRC support, consistent with an active CoA-transfer step within the degradation cycle.
• Type2_MinCycle_Coloc (P99-P100): very strong minimal-cycle colocalization, suggesting robust functional assembly of the core Type II degradation loop.
• Type2_FullModule_Coloc (P99-P100): very strong full-module colocalization, supporting a highly coherent Type II oxalate-handling module.
• T2C_TypeII_Completeness (P99-P100): very high proportional completeness of the Type II module relative to its marker pool.
• Type2_Score (P95-P99): strong overall Type II degradation composite, integrating enzyme abundance with modular organization.
• OPI_Oxalate_Protection_Index (P75-P95): mildly high protective composite, indicating favorable balance of degradation over synthesis pressure.
• OI_Oxalobacter_Index (P99-P100): very strong specialised oxalate-degradation index, consistent with a highly protective Type II-oriented signal.
• DPR_Degradation_Production_Ratio (P75-P95): mildly high degradation-to-production balance, favoring oxalate handling rather than net pro-oxalate pressure.

Axis Convergence & Cross-Axis Interactions

The axis pattern is notably coherent. Axis A shows strong Type II enzymatic support, led by high Type2_OXC_total and supported by Type2_FRC_total, while Type2_OxlT_total remains within the typical range rather than showing a mismatch. Axis B is especially strong, with both minimal-cycle and full-module colocalization in P99-P100, indicating that the enzymatic signal is not isolated but organized into a functionally plausible module.

Axis C adds redundancy: Type1_OxDC_total is detected and falls in P75-P95, which suggests a supportive backup degradation route rather than sole dependence on Type II. Axis D does not show pro-oxalate pressure, because Oxalate_Synthesis_Score is in P25-P50. This makes the favorable DPR orientation biologically consistent rather than contradictory.

Overall, degradation-related axes and composite indexes point in the same direction, and there is no competing high synthesis signal.

Composite Index Analysis

The composite indexes are concordant with the axis-level findings. OPI_Oxalate_Protection_Index in P75-P95 indicates above-typical protective balance, driven mainly by strong Type II module strength. DPR_Degradation_Production_Ratio in P75-P95 suggests degradation potential outweighs production potential. Oxalate_Stone_Risk_Index in P5-P25 is favorable and aligns with the same interpretation from the opposite direction.

In practical terms, the composite layer does not introduce conflict; it reinforces the impression of adequate-to-strong protective oxalate handling potential.

Clinical Picture (Functional Hypothesis)